ArticlePatient preference and adherence2026

Patient-Reported Outcomes with Long-Acting Cabotegravir and Rilpivirine in People Living with HIV.

Ana Codonal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.